Timothy B. Meier

Timothy B. Meier

Auto-generated profile, based on publicly available information

Timothy B. Meier

Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2015 in Human Brain Mapping
Verified
Journal Article
Closed access
TMTimothy B. Meier
Timothy B. Meier
MBMaurizio Bergamino
Maurizio Bergamino
PBPatrick S. F. Bellgowan
Patrick S. F. Bellgowan
KTKent Teague
Kent Teague
JLJosef M. Ling
Josef M. Ling
AMAndrew R. Mayer
Andrew R. Mayer

25 March 2020 in Annals of Neurology
Verified
Journal Article
Open access
PDF file
TMTimothy B. Meier
Timothy B. Meier
DHDaniel L. Huber
Daniel L. Huber
LBLuisa Bohorquez‐Montoya
Luisa Bohorquez‐Montoya
MNMorgan E. Nitta
Morgan E. Nitta
JSJonathan Savitz
Jonathan Savitz
MMMichael A. McCrea
Michael A. McCrea
Objective: Prospectively characterize changes in serum proteins following sport‐related concussion and determine whether candidate biomarkers discriminate concussed athletes from controls and are associated with duration of symptoms following concussion.Methods: High school and collegiate athletes were enrolled between 2015 and 2018. Blood was collected at preinjury baseline and within 6 hours (early acute) and at 24 to 48 hours (late acute) following concussion in football players (n = 106), matched uninjured football players (n = 84), and non–contact‐sport athletes (n = 50). Glial fibrillary acidic protein, ubiquitin c‐terminal hydrolase‐L1, S100 calcium binding protein B, alpha‐II‐spectrin breakdown product 150, interleukin 6, interleukin 1 receptor antagonist, and c‐reactive protein were measured in serum. Linear models assessed changes in protein concentrations over time. Receiver operating curves quantified the discrimination of concussed athletes from controls. A Cox proportional hazard model determined whether proteins were associated with symptom recovery.Results: All proteins except glial fibrillary acidic protein and c‐reactive protein were significantly elevated at the early acute phase postinjury relative to baseline and both control groups and discriminated concussed athletes from controls with areas under the curve of 0.68 to 0.84. The candidate biomarkers also significantly improved the discrimination of concussed athletes from noncontact controls compared to symptom severity alone. Glial fibrillary acidic protein was elevated postinjury relative to baseline in concussed athletes with a loss of consciousness or amnesia. Finally, early acute levels of interleukin 1 receptor antagonist were associated with the number of days to symptom recovery.Interpretation: Brain injury and inflammatory proteins show promise as objective diagnostic biomarkers for sport‐related concussion, and inflammatory markers may provide prognostic value. ANN NEUROL 2020;87:907–920

30 July 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
MNMorgan E. Nitta
Morgan E. Nitta
JSJonathan Savitz
Jonathan Savitz
LNLindsay D. Nelson
Lindsay D. Nelson
TTT. Kent Teague
T. Kent Teague
JHJames B. Hoelzle
James B. Hoelzle
TMTimothy B. Meier
Timothy B. Meier
Objective To test the hypothesis that acute elevations in serum inflammatory markers predict symptom recovery after sport-related concussion (SRC). Methods High school and collegiate football players (n = 857) were prospectively enrolled. Forty-one athletes with concussion and 43 matched control athletes met inclusion criteria. Serum levels of interleukin (IL)–6, IL-1β, IL-10, tumor necrosis factor, C-reactive protein, interferon-γ, and IL-1 receptor antagonist and Sport Concussion Assessment Tool, 3rd edition (SCAT3) symptom severity scores were collected at a preinjury baseline, 6 and 24–48 hours postinjury, and approximately 8, 15, and 45 days following concussion. The number of days that athletes were symptomatic following SRC (i.e., duration of symptoms) was the primary outcome variable. Results IL-6 and IL-1RA were significantly elevated in athletes with concussion at 6 hours relative to preinjury and other postinjury visits, as well as compared to controls (ps ≤ 0.001). IL-6 and IL-1RA significantly discriminated concussed from control athletes at 6 hours postconcussion (IL-6 area under receiver operating characteristic curve 0.79 [95% confidence interval (CI) 0.65–0.92], IL-1RA AUC 0.79 [95% CI 0.67–0.90]). Further, IL-6 levels at 6 hours postconcussion were significantly associated with the duration of symptoms (hazard ratio for symptom recovery = 0.61 [95% CI 0.38–0.96], p = 0.031). Conclusions Results support the potential utility of IL-6 and IL-1RA as serum biomarkers of SRC and demonstrate the potential of these markers in identifying athletes at risk for prolonged recovery after SRC. Classification of evidence This study provides Class III evidence that serum levels of IL-6 and IL-1RA 6 hours postconcussion significantly discriminated concussed from control athletes.

31 May 2021 in Biological Psychiatry
Verified
Journal Article
Closed access
TMTimothy B. Meier
Timothy B. Meier
JSJonathan Savitz
Jonathan Savitz

15 November 2017 in Journal of Neurotrauma
Verified
Journal Article
Closed access
TMTimothy B. Meier
Timothy B. Meier
LNLindsay D. Nelson
Lindsay D. Nelson
DHDaniel L. Huber
Daniel L. Huber
JBJeffrey J Bazarian
Jeffrey J Bazarian
RHRonald L. Hayes
Ronald L. Hayes
MMMichael A. McCrea
Michael A. McCrea
There is a pressing need to identify objective biomarkers for the assessment of sport-related concussion to reduce the reliance on clinical judgment for the management of these injuries. The goal of the current study was to prospectively establish the acute effects of sport-related concussion (SRC) on serum levels of S100B, GFAP, and UCH-L1. Collegiate and high school football players were enrolled and provided blood at preseason. Injured athletes participated in follow-up visits at approximately 6 and 24-48 hours following documented SRC (N=32). Non-injured football players participated in similar follow-up visits and served as controls (N=29). The median time between injury and blood collection was 2 hours (6-hour visit) and 22.5 hours (24-48-hour visit) in concussed athletes. Concussed athletes had significantly elevated UCH-L1 levels at the 6-hour visit relative to preseason levels (Z=2.22, p=0.03) and levels in control athletes (Z=3.02, p=0.003). Concussed athletes also had elevated S100B at 6 hours relative to preseason (Z=2.07, p=0.04) and controls (Z=2.75, p=0.006). Both markers showed fair discrimination between concussed and control athletes (UCH-L1 AUC[95% confidence internal]=0.74 [0.61-0.88], S100B AUC=0.72 [0.58-0.87]). Percent-change of UCH-L1 and S100B at 6 hours relative to preseason also showed fair discrimination (AUC=0.79[0.66-0.92] and AUC=0.77[0.64-0.90]). GFAP levels did not differ between groups or in concussed athletes relative to preseason. This study provides prospective evidence of significant increases in serum levels of UCH-L1 and S100B during the early acute period following SRC and lays the foundation for future studies examining the clinical potential for blood-based biomarkers in the early detection of concussion.

28 January 2016 in Brain Imaging and Behavior
Verified
Journal Article
Closed access
PDF file
TMTimothy B. Meier
Timothy B. Meier
PBPatrick S. F. Bellgowan
Patrick S. F. Bellgowan
AMAndrew R. Mayer
Andrew R. Mayer